Search Results - "Calamia, Justina C"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Pharmacokinetics of Tacrolimus During Pregnancy by SONGMAO ZHENG, EASTERLING, Thomas R, UMANS, Jason G, MIODOVNIK, Menachem, CALAMIA, Justina C, THUMMEL, Kenneth E, SHEN, Danny D, DAVIS, Connie L, HEBERT, Mary F

    Published in Therapeutic drug monitoring (01-12-2012)
    “…Information on the pharmacokinetics of tacrolimus during pregnancy is limited to case reports despite the increasing number of pregnant women being prescribed…”
    Get full text
    Journal Article
  2. 2

    Variability in Expression of CYP3A5 in Human Fetal Liver by Vyhlidal, Carrie A, Pearce, Robin E, Gaedigk, Roger, Calamia, Justina C, Shuster, Diana L, Thummel, Kenneth E, Leeder, J Steven

    Published in Drug metabolism and disposition (01-08-2015)
    “…Members of the cytochrome P450 3A (CYP3A) subfamily of drug metabolizing enzymes exhibit developmental changes in expression in human liver characterized by a…”
    Get full text
    Journal Article
  3. 3

    Identification of CYP3A7 for glyburide metabolism in human fetal livers by Shuster, Diana L., Risler, Linda J., Prasad, Bhagwat, Calamia, Justina C., Voellinger, Jenna L., Kelly, Edward J., Unadkat, Jashvant D., Hebert, Mary F., Shen, Danny D., Thummel, Kenneth E., Mao, Qingcheng

    Published in Biochemical pharmacology (15-12-2014)
    “…Glyburide is commonly prescribed for the treatment of gestational diabetes mellitus; however, fetal exposure to glyburide is not well understood and may have…”
    Get full text
    Journal Article
  4. 4

    EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM by WEILI HUANG, LIN, Yvonne S, MCCONN, Donavon J, CALAMIA, Justina C, TOTAH, Rheem A, ISOHERRANEN, Nina, GLODOWSKI, Mary, THUMMEL, Kenneth E

    Published in Drug metabolism and disposition (01-12-2004)
    “…CYP3A4 and CYP3A5 exhibit significant overlap in substrate specificity but can differ in product regioselectivity and formation activity. To further explore…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Tacrolimus placental transfer at delivery and neonatal exposure through breast milk by Zheng, Songmao, Easterling, Thomas R., Hays, Karen, Umans, Jason G., Miodovnik, Menachem, Clark, Shannon, Calamia, Justina C., Thummel, Kenneth E., Shen, Danny D., Davis, Connie L., Hebert, Mary F.

    Published in British journal of clinical pharmacology (01-12-2013)
    “…Aim(s) The current investigation aims to provide new insights into fetal exposure to tacrolimus in utero by evaluating maternal and umbilical cord blood…”
    Get full text
    Journal Article
  9. 9

    CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition by Zheng, Songmao, Tasnif, Yasar, Hebert, Mary F, Davis, Connie L, Shitara, Yoshihisa, Calamia, Justina C, Lin, Yvonne S, Shen, Danny D, Thummel, Kenneth E

    Published in Transplantation (27-03-2013)
    “…Higher concentrations of AM19 and AM1c9, secondary metabolites of cyclosporine A (CsA), have been associated with nephrotoxicity in organ transplant patients…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Transiently altered acetaminophen metabolism after liver transplantation by Park, Jeong M., Lin, Yvonne S., Calamia, Justina C., Thummel, Kenneth E., Slattery, John T., Kalhorn, Thomas F., Carithers, Robert L., Levy, Adam E., Marsh, Christopher L., Hebert, Mary F.

    Published in Clinical pharmacology and therapeutics (01-06-2003)
    “…Background and objectives: Acetaminophen (INN, paracetamol) is metabolized to N‐acetyl‐p‐benzoquinone imine (NAPQI), a hepatotoxic metabolite, predominantly by…”
    Get full text
    Journal Article
  12. 12

    Midazolam metabolism by modified Caco-2 monolayers: effects of extracellular protein binding by Fisher, J M, Wrighton, S A, Calamia, J C, Shen, D D, Kunze, K L, Thummel, K E

    “…It has been suggested that the binding of a drug to plasma proteins will influence the intestinal extraction efficiency when drug is delivered to the mucosal…”
    Get more information
    Journal Article
  13. 13

    CYP3A5 Gene Variation Influences both Systemic and Intrarenal Tacrolimus Disposition by Zheng, Songmao, Tasnif, Yasar, Hebert, Mary F., Davis, Connie L., Shitara, Yoshihisa, Calamia, Justina C., Lin, Yvonne S., Shen, Danny D., Thummel, Kenneth E.

    Published in Clinical pharmacology and therapeutics (17-10-2012)
    “…We evaluated the hypothesis that CYP3A5 expression can affect intrarenal tacrolimus accumulation. An oral dose of tacrolimus was administered to 24 healthy…”
    Get full text
    Journal Article
  14. 14